The Top 5 Blog Posts of 2021
As we wrap up 2021, let’s revisit the top five blog posts of the year. While our team of pharmacy benefit experts here at RxBenefits continually evaluates cost-saving strategies to bring you the latest and greatest insights from the complex world of PBM, a few of our blog posts resonated the most.
Rebates have been around for a long time – but now those rebates are being consolidated by manufacturers. The goal of consolidating rebates is to maximize the market share within a formulary. Most drug rebates now are attached to the expensive brand-name drug, particularly with specialty medications.
Managing appropriate use of specialty medications requires strategies that go beyond traditional pharmacy management. To shed light on the true impact of specialty drugs on pharmacy benefits, check out this list of our top 10 specialty Rx numbers to know from 2021.
It is critical to conduct a careful analysis before deciding which type of pharmacy pricing arrangement works in your client’s best financial interests. Both a traditional contract and a pass-through/transparent contract have pros and cons. Understanding each of these contract types can provide valuable insight into what your clients can expect.
When considering carving in versus out your pharmacy benefits plan, it’s important to understand the key differences. As your pharmacy benefit experts, we break down the details and look at everything from guarantees, rebates, single-source generic language and clinical opportunities to eliminate waste and to maximize healthcare outcomes for members.
When either outside influencers or drug manufactures specify that the pharmacist dispenses a multi-source brand-name drug when a generic equivalent exists, it’s referred to as a Dispense as Written (DAW) prescription. Dispense as Written prescriptions continue to negatively impact pharmacy plan costs. DAW penalties help to promote cost-conscious decision-making without resorting to an exclusionary formulary.